Clinical Trial Update: PrEP4Her: Developing a Novel Strategy to Implement PrEP Into Women's Healthcare

View source ↗

Summary

Completed clinical trial evaluating a novel strategy to implement HIV PrEP in women's healthcare; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Descovy (emtricitabine/tenofovir alafenamide)
• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: PrEP Precriptions for Reproductive Aged Women | Status: COMPLETED | Results posted: 2026-01-26